SCH79797 is primarily utilized in research settings as a potent and selective antagonist of protease-activated receptor 1 (PAR1). It is widely used in studies focused on understanding the role of PAR1 in various physiological and pathological processes, such as thrombosis, inflammation, and cancer. Researchers employ SCH79797 to investigate the mechanisms of PAR1 signaling and its impact on cellular functions, including platelet activation, endothelial cell behavior, and tumor progression. Its application extends to preclinical models where it helps evaluate the therapeutic potential of PAR1 inhibition in conditions like cardiovascular diseases and metastatic cancers. Additionally, SCH79797 serves as a valuable tool in drug discovery efforts aimed at developing novel PAR1-targeted therapies.